The Juvenile Diabetes Cure Alliance (JDCA) profiled SymbioCellTech in its recent report on small to mid-size corporations - both public and private - that are conducting work that could directly or indirectly support a practical cure. JDCA determines which commercial entities are advancing a potential Practical Cure with screening metrics that evaluate stage of development, funding, and technology.